Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland

Endocrinology

Volumn 144, Issue 6, 2003, Pages 2683-2694

  Lee, Adrian V ^a   Zhang, P ^a   Ivanova, M ^a   Bonnette, S ^a,b   Oesterreich, S ^a   Rosen, J M ^a   Grimm, S ^a   Hovey, R C ^a,c,e   Vonderhaar, B K ^a,c   Kahn, C R ^a,d   Torres, D ^a   George, J ^a   Mohsin, S ^a   Allred, D C ^a   Hadsell, D L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; PROGESTERONE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BODY SIZE; BREAST DEVELOPMENT; CONFERENCE PAPER; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONE ACTION; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; OVARIECTOMY; PREGNANCY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; ESTROGENS; ESTROUS CYCLE; FEMALE; GENE EXPRESSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED STRAINS; OVARIECTOMY; PHOSPHOPROTEINS; PREGNANCY; PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 0037508559     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-221103     Document Type: Conference Paper

References (62)

1. Williams JM, Daniel CW 1983 Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol 97:274-290
2. Hennighausen L, Robinson GW 1998 Think globally, act locally: the making of a mouse mammary gland. Genes Dev 12:449-455
3. Bocchinfuso WP, Korach KS 1997 Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2:323-334
4. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R, Korach KS 2000 Induction of mammary gland development in estrogen receptor-α knockout mice. Endocrinology 141:2982-2994
5. Cunha GR, Young P, Hom YK, Cooke PS, Taylor JA, Lubahn DB 1997 Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J Mammary Gland Biol Neoplasia 2:393-402
6. Mueller SO, Clark JA, Myers PH, Korach KS 2002 Mammary gland development in adult mice requires epithelial and stromal estrogen receptor α. Endocrinology 143:2357-2365
7. Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, Kopchick JJ, Oka T, Kelly PA, Hennighausen L 2001 Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol 229:163-175
8. Ruan W, Kleinberg DL 1999 Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140:5075-5081
9. Kleinberg DL, Feldman M, Ruan W 2000 IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 5:7-17
10. Stull M, Richert M, Wood T 2000 IGF-mediated growth of mammary epithelium during ductal development in the mouse. Growth Hormone IGF Res 9:320
11. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
12. Bonnette SG, Hadsell DL 2001 Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142:4937-4945
13. Humphreys RC, Lydon JP, O'Malley BW, Rosen JM 1997 Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia 2:343-354
14. Seagroves TN, Lydon JP, Hovey RC, Vonderhaar BK, Rosen JM 2000 C/EBPβ (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol 14:359-368
15. Grimm SL, Seagroves TN, Kabotyanski EB, Hovey RC, Vonderhaar BK, Lydon JP, Miyoshi K, Hennighausen L, Ormandy CJ, Lee AV, Stull MA, Wood TL, Rosen JM 2002 Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol Endocrinol 16:2675-2691
16. Ormandy CJ, Binart N, Kelly PA 1997 Mammary gland development in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia 2:355-364
17. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF 1991 Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77
18. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers Jr MG, Glasheen E, Lane WS, Pierce JH, White MF 1995 Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-177
19. Smith-Hall J, Pons S, Patti ME, Burks DJ, Yenush L, Sun XJ, Kahn CR, White MF 1997 The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry 36:8304-8310
20. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE 1997 A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272:21403-21407
21. Yenush L, White MF 1997 The IRS-signalling system during insulin and cytokine action. BioEssays 19:491-500
22. Araki E, Lipes MA, Patti ME, Bruning JC, Haag 3rd B, Johnson RS, Kahn CR 1994 Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190
23. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904
24. Berlanga JJ, Gualillo O, Buteau H, Applanat M, Kelly PA, Edery M 1997 Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase. J Biol Chem 272:2050-2052
25. Yamauchi T, Kaburagi Y, Ueki K, Tsuji Y, Stark GR, Kerr IM, Tsushima T, Akanuma Y, Komuro I, Tobe K, Yazaki Y, Kadowaki T 1998 Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J Biol Chem 273:15719-15726
26. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D 1999 Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13:787-796
27. Mauro L, Salerno M, Panno ML, Bellizzi D, Sisci D, Miglietta A, Surmacz E, Ando S 2001 Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells. Biochem Biophys Res Commun 288:685-689
28. Molloy CA, May FE, Westley BR 2000 Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J Biol Chem 275:12565-12571
29. Vassen L, Wegrzyn W, Klein-Hitpass L 1999 Human insulin receptor substrate-2 (IRS-2) is a primary progesterone response gene. Mol Endocrinol 13:485-494
30. Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, Sundararajan K, Vonderhaar BK 2001 Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn 222:192-205
31. Rugh R 1980 Reproductive systems of adult mice. In: The mouse: its reproduction and development. New York: Oxford University Press; 7-43
32. Hadsell DL, Alexeenko T, Klemintidis Y, Torres D, Lee AV 2001 Inability of overexpressed des(1-3)human insulin-like growth factor I (IGF-I) to inhibit forced mammary gland involution is associated with decreased expression of IGF signaling molecules. Endocrinology 142:1479-1488
33. Valle LD, Wang JY, Lassak A, Peruzzi F, Croul S, Khalili K, Reiss K 2002 Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors-medulloblastomas. J Neurovirol 8(Suppl 2):138-147
34. Boylan JM, Gruppuso PA 2002 Insulin receptor substrate-1 is present in hepatocyte nuclei from intact rats. Endocrinology 143:4178-4183
35. Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B, Baserga R 2002 Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis. J Biol Chem 277:44357-44365
36. Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A, Baserga R 2002 Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J Biol Chem 277:32078-32085
37. Lassak A, Del Valle L, Peruzzi F, Wang JY, Enam S, Croul S, Khalili K, Reiss K 2002 Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem 277:17231-17238
38. Silberstein GB, Van Horn K, Shyamala G, Daniel CW 1996 Progesterone receptors in the mouse mammary duct: distribution and developmental regulation. Cell Growth Differ 7:945-952
39. Shyamala G, Chou YC, Louie SG, Guzman RC, Smith GH, Nandi S 2002 Cellular expression of estrogen and progesterone receptors in mammary glands: regulation by hormones, development and aging. J Steroid Biochem Mol Biol 80:137-148
40. Zeps N, Bentel JM, Papadimitriou JM, D'Antuono MF, Dawkins HJ 1998 Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation 62:221-226
41. Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S, Reed JC, Rosen JM 1996 Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development 122: 4013-4022
42. Fata JE, Chaudhary V, Khokha R 2001 Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17β-estradiol during the estrous cycle. Biol Reprod 65:680-688
43. Walmer DK, Wrona MA, Hoghes CL, Nelson KG 1992 Lactoferrin expression in hte mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology 131:1458-1466
44. Richert MM, Wood TL 1999 The insulin-like growth factors (IGF) and IGF type 1 receptor during postnatal growth of the murine mammary gland: sites of messenger ribonucleic acid expression and potential functions. Endocrinology 140:454-461
45. Robinson GW, McKnight RA, Smith GH, Hennighausen L 1995 Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121:2079-2090
46. Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ, Vonderhaar BK 2003 Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol Endocrinol 17:460-471
47. Franks S 1983 Regulation of prolactin secretion by oestrogens: physiological and pathological significance. Clin Sci (Lond) 65:457-462
48. Guillaumot P, Cohen H 1994 Heterogeneity of the prolactin receptor in the rat mammary gland and liver during various physiological states. J Endocrinol 141:271-278
49. Mizoguchi Y, Kim JY, Enami J, Sakai S 1997 The regulation of the prolactin receptor gene expression in the mammary gland of early pregnant mouse. Endocr J 44:53-58
50. Bayna EM, Rosen JM 1990 Tissue-specific, high level expression of the rat whey acidic protein gene in transgenic mice. Nucleic Acids Res 18:2977-2985
51. Burdon T, Sankaran L, Wall RJ, Spencer M, Hennighausen L 1991 Expression of a whey acidic protein transgene during mammary development. Evidence for different mechanisms of regulation during pregnancy and lactation. J Biol Chem 266:6909-6914
52. Master SR, Hartman JL, D'Cruz CM, Moody SE, Keiper EA, Ha SI, Cox JD, Belka GK, Chodosh LA 2002 Functional microarray analysis of mammary organogenesis reveals a developmental role in adaptive thermogenesis. Mol Endocrinol 16:1185-1203
53. Binart N, Ormandy CJ, Kelly PA 2000 Mammary gland development and the prolactin receptor. Adv Exp Med Biol 480:85-92
54. Sun XJ, Goldberg JL, Qiao LY, Mitchell JJ 1999 Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48:1359-1364
55. Lee AV, Gooch JL, Oesterreich S, Guler RL, Yee D 2000 Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3′-kinase inhibition. Mol Cell Biol 20:1489-1496
56. Bohni R, Riesgo-Escovar J, Oldham S, Brogiolo W, Stocker H, Andruss BF, Beckingham K, Hafen E 1999 Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97:865-875
57. Araki E, Lipes MA, Patti M, Bruning JC, Haag III B, Johnson RS, Kahn CR 1994 Alternative pathway of insulin-signaling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190
58. Nolan MK, Jankowska L, Prisco M, Xu S, Guvakova MA, Surmacz E 1997 Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells. Int J Cancer 72:828-834
59. Bruning JC, Winnay J, Cheatham B, Kahn CR 1997 Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 17:1513-1521
60. Sivaraman L, Stephens LC, Markaverich BM, Clark JA, Krnacik S, Conneely OM, O'Malley BW, Medina D 1998 Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis 19:1573-1581
61. 1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50:2164-2168
62. Marasco L, Marmet C, Shell E 2000 Polycystic ovary syndrome: a connection to insufficient milk supply? J Hum Lact 16:143-148